Cerner LifeSciences, Beverly Hills, Irvine, California 90212, USA.
Cephalalgia. 2010 May;30(5):599-609. doi: 10.1111/j.1468-2982.2009.01941.x.
The aim of this review was to summarize population-based studies reporting prevalence and/or incidence of chronic migraine (CM) and to explore variation across studies. A systematic literature search was conducted. Relevant data were abstracted and estimates were subdivided based on the criteria used in each study. Sixteen publications representing 12 studies were accepted. None presented data on CM incidence. The prevalence of CM was 0-5.1%, with estimates typically in the range of 1.4-2.2%. Seven studies used Silberstein-Lipton criteria (or equivalent), with prevalence ranging from 0.9% to 5.1%. Three estimates used migraine that occurred ≥15 days per month, with prevalence ranging from 0 to 0.7%. Prevalence varied by World Health Organization region and gender. This review identified population-based studies of CM prevalence, although heterogeneity across studies and lack of data from certain regions leaves an incomplete picture. Future studies on CM would benefit from an International Classification of Headache Disorders consensus diagnosis that is clinically appropriate and operational in epidemiological studies.
本综述的目的是总结报告慢性偏头痛（CM）患病率和/或发病率的基于人群的研究，并探讨研究间的差异。进行了系统的文献检索。摘录了相关数据，并根据每项研究中使用的标准对估计值进行了细分。有 16 篇出版物代表了 12 项研究，被接受纳入。没有研究报告 CM 发病率的数据。CM 的患病率为 0-5.1%，估计值通常在 1.4-2.2%之间。7 项研究使用了 Silberstein-Lipton 标准（或同等标准），患病率范围为 0.9%至 5.1%。有 3 个估计值使用每月偏头痛发作≥15 天，患病率范围为 0 至 0.7%。患病率因世界卫生组织区域和性别而异。本综述确定了 CM 患病率的基于人群的研究，但研究间存在异质性，并且某些地区缺乏数据，使得情况并不完整。未来关于 CM 的研究将受益于国际头痛疾病分类共识诊断，该诊断在临床和流行病学研究中具有适当性和可操作性。
